KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P33
Within normal range
Average
41.77%
Historical baseline
PeriodValue
20250.00%
20240.00%
20230.00%
20220.00%
2021-100.00%
2020-21.31%
201992.13%
2018458.11%
2017-29.49%
201618.24%